DRUG · Unmapped registry intervention
PRL-02 injection
Find medicine records ·
Find other trials using this name
Clinical trial
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
NCT04729114
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
prednisone
Normalized identity: prednisoneView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
dexamethasone
Normalized identity: dexamethasoneView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
enzalutamide
Normalized identity: enzalutamideView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
PRL-02 injectionDRUG
prednisoneDRUG · verified · RxNorm: prednisone
dexamethasoneDRUG · verified · RxNorm: dexamethasone
enzalutamideDRUG · verified · RxNorm: enzalutamide
Sponsors & collaborators
Astellas Pharma Global Development, Inc.lead sponsor
Mapped research locations
HoustonTexas, United States2DallasTexas, United States1San AntonioTexas, United States1NashvilleTennessee, United States1TampaFlorida, United States1DurhamNorth Carolina, United States1OmahaNebraska, United States1TucsonArizona, United States1BethesdaMaryland, United States1AlbuquerqueNew Mexico, United States1WichitaKansas, United States1CharlottesvilleVirginia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04729114 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.